Dashboard
Manage Tickers

PFEPFIZER INC


$ 29.76 $ -0.08 (-0.27 %)    

Wednesday, 18-Sep-2024 15:59:57 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 472.49 $ -2.05 (-0.43 %)
DIA $ 416.26 $ -1.07 (-0.26 %)
SPY $ 562.20 $ -1.67 (-0.3 %)
TLT $ 99.62 $ -1.25 (-1.24 %)
GLD $ 235.53 $ -1.83 (-0.77 %)
$ na
$ 30.00
$ 29.75 x 3,000
-- x --
$ 29.74 - $ 30.13
$ 24.48 - $ 32.21
25,812,847
na
168.58B
$ 0.54
nm
TBD
na
na ($ 0.06)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
09/18/2024 17:35:25

jim-cramer-labels-moderna-a-big-disappointment-but-suggests-doubling-down-on-another-pharma-powerhouse
Jim Cramer Labels Moderna A 'Big Disappoin...
09/18/2024 12:06:16

Jim Cramer likes Pfizer and recommends buying more stock. Six Flags is struggling, but Cramer likes First Solar and Equity Resi...

pfizer-unusual-options-activity
Pfizer Unusual Options Activity
09/17/2024 14:01:44

intel-microsoft-meta-platforms-pfizer-tesla-why-these-5-stocks-are-on-investors-radars-today
Intel, Microsoft, Meta Platforms, Pfizer, ...
09/17/2024 02:50:27

On Monday, major U.S. indices showed mixed results. The Dow Jones Industrial Average closed 0.5% higher at 41,622.08

beyond-the-numbers-13-analysts-discuss-pfizer-stock
Beyond The Numbers: 13 Analysts Discuss Pf...
09/16/2024 21:00:48

cantor-fitzgerald-reiterates-overweight-on-pfizer-maintains-45-price-target
Cantor Fitzgerald Reiterates Overweight on...
09/16/2024 16:25:29

Cantor Fitzgerald analyst Louise Chen reiterates Pfizer (NYSE:PFE) with a Overweight and maintains $45 price target.

desantis-administration-cautions-against-pfizer-moderna-mrna-covid-vaccines-for-vulnerable-individuals-cites-concerns-related-to-rare-heart-conditions
DeSantis Administration Cautions Against P...
09/16/2024 15:18:10

Florida advises against mRNA Covid vaccines for vulnerable residents, citing safety concerns. Gov. DeSantis' administration...

pfizer-presents-positive-data-from-phase-2-study-of-ponsegromab-in-patients-with-cancer-cachexia
Pfizer Presents Positive Data from Phase 2...
09/16/2024 08:19:28

Study met primary endpoint of change from baseline in body weight for ponsegromab compared to placebo across all ponsegromab ...

reported-saturday-pfizers-braftovi--mektovi-shows-long-term-efficacy-in-braf-v600e-mutant-metastatic-non-small-cell-lung-cancer-patients-after-three-year-follow-up
Reported Saturday, Pfizer's BRAFTOVI + MEK...
09/16/2024 08:17:38

BRAFTOVI + MEKTOVI continued to show substantial antitumor activity after a minimum follow up of approximately three years, c...

Core News & Articles
"Florida Discourages Use Of mRNA Covid Vac...
09/13/2024 17:21:41

https://www.nbcnews.com/health/health-news/florida-covid-shots-mrna-vaccines-older-adults-rcna170997Even as the Covid wave in F...

Core News & Articles
North Dakota Judge Overturns State's Abort...
09/12/2024 17:53:13

- Reuters

unitedhealth-follows-competitors-replaces-humira-with-lower-cost-biosimilars
UnitedHealth Follows Competitors, Replaces...
09/11/2024 18:59:13

UnitedHealth will remove AbbVie's Humira from its preferred drug lists by 2025, opting for lower-cost biosimilars like Amge...

gsk-halts-herpes-simplex-virus-vaccine-development-clears-path-for-other-contenders-like-moderna-biontech
GSK Halts Herpes Simplex Virus Vaccine Dev...
09/11/2024 16:13:09

GSK Plc has halted development of its herpes simplex virus vaccine, GSK3943104, after it failed to meet efficacy goals in clini...

enliven-therapeutics-leukemia-candidate-could-challenge-pfizer-astrazeneca-in-broader-target-market-analyst
Enliven Therapeutics' Leukemia Candidate C...
09/09/2024 18:05:21

HC Wainwright initiated coverage on Enliven Therapeutics, noting its innovative small molecules for tumor treatments. HC Wainwr...

why-is-moderna-stock-trading-higher-on-monday
Why Is Moderna Stock Trading Higher On Mon...
09/09/2024 17:00:47

Moderna's Laval, Quebec, facility received a Drug Establishment License from Health Canada, allowing it to produce mRNA vac...

cantor-fitzgerald-reiterates-overweight-on-pfizer-maintains-45-price-target
Cantor Fitzgerald Reiterates Overweight on...
09/09/2024 15:56:03

Cantor Fitzgerald analyst Louise Chen reiterates Pfizer (NYSE:PFE) with a Overweight and maintains $45 price target.

relay-therapeutics-advances-towards-pivotal-trial-as-it-shares-encouraging-breast-cancer-data-in-heavily-pretreated-patients
Relay Therapeutics Advances Towards Pivota...
09/09/2024 15:30:00

Monday, Relay Therapeutics Inc. (NASDAQ:RLAY) shared interim data for RLY-2608 from ReDiscover study, an ongoing first-in-human...

bicycle-therapeutics-lead-cancer-candidates-has-high-opportunity-analyst-initiates-with-bullish-tone
Bicycle Therapeutics' Lead Cancer Candidat...
09/06/2024 17:37:16

RBC Capital initiates coverage on Bicycle Therapeutics, highlighting Zelenectide's potential in oncology with improved safe...

fda-battles-backlog-of-drug-factory-inspections-since-covid-19
FDA Battles Backlog of Drug Factory Inspec...
09/06/2024 15:52:51

FDA faces inspection backlog with serious public health implications, as critical drug manufacturing plants remain unchecked.

whats-going-on-with-penny-stock-blood-cancer-focused-vor-biopharma-on-friday
What's Going On With Penny Stock Blood Can...
09/06/2024 13:35:08

Vor Biopharma reveals promising Phase 1/2 study results for AML treatment, and it is planning FDA pivotal trial discussions.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION